Gene · 1399
Papers2,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in deciphering the interactions between viral proteins of influenza A virus and host cellular proteins. | Cell Insight | 2023 | 37193064 | PubTator, text mining | PubMed |
| Role of Some microRNA/ADAM Proteins Axes in Gastrointestinal Cancers as a Novel Biomarkers and Potential Therapeutic Targets-A Review. | Curr Issues Mol Biol | 2023 | 37185715 | PubTator, text mining | PubMed |
| Chromosome 22q11.2 Deletion Syndrome: A Comprehensive Review of Molecular Genetics in the Context of Multidisciplinary Clinical Approach. | Int J Mol Sci | 2023 | 37176024 | PubTator, text mining | PubMed |
| Network analysis reveals a major role for 14q32 cluster miRNAs in determining transcriptional differences between IGHV-mutated and unmutated CLL. | Leukemia | 2023 | 37169950 | PubTator, text mining | PubMed |
| A CRISPR-engineered isogenic model of the 22q11.2 A-B syndromic deletion. | Sci Rep | 2023 | 37169815 | PubTator, text mining | PubMed |
| Inhibition of casein kinase 2 induces cell death in tyrosine kinase inhibitor resistant chronic myelogenous leukemia cells. | PLoS One | 2023 | 37141212 | PubTator, text mining | PubMed |
| RNA binding protein PRRC2B mediates translation of specific mRNAs and regulates cell cycle progression. | Nucleic Acids Res | 2023 | 37125639 | PubTator, text mining | PubMed |
| Lateral thinking in syndromic congenital cardiovascular disease. | Dis Model Mech | 2023 | 37125615 | PubTator, text mining | PubMed |
| Circular RNAs: pivotal role in the leukemogenesis and novel indicators for the diagnosis and prognosis of acute myeloid leukemia. | Front Oncol | 2023 | 37124518 | PubTator, text mining | PubMed |
| A review of signal pathway induced by virulent protein CagA of Helicobacter pylori. | Front Cell Infect Microbiol | 2023 | 37124036 | PubTator, text mining | PubMed |
| Identification of CRKL as an oncogenic biomarker for prognosis and immunotherapy in melanoma, and its potential molecular mechanism. | Genomics | 2023 | 37121446 | PubTator, text mining | PubMed |
| Comprehensive proteome, phosphoproteome and kinome characterization of luminal A breast cancer. | Front Oncol | 2023 | 37064116 | PubTator, text mining | PubMed |
| Transformation of ALK-positive NSCLC to SCLC after alectinib resistance and response to combined atezolizumab: a case report. | Transl Lung Cancer Res | 2023 | 37057117 | PubTator, text mining | PubMed |
| Small Non-Coding RNAs in Soft-Tissue Sarcomas: State of the Art and Future Directions. | Mol Cancer Res | 2023 | 37052491 | PubTator, text mining | PubMed |
| Role of CD34 in inflammatory bowel disease. | Front Physiol | 2023 | 37051017 | PubTator, text mining | PubMed |
| ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1. | Proc Natl Acad Sci U S A | 2023 | 37040401 | PubTator, text mining | PubMed |
| Iruplinalkib (WX‑0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancer. | Invest New Drugs | 2023 | 37036582 | PubTator, text mining | PubMed |
| Case Report: Clinical response to anaplastic lymphoma kinase inhibitor-based targeted therapy in uterine inflammatory myofibroblastic tumor harboring ALK-IGFBP5 fusion. | Front Oncol | 2023 | 37035208 | PubTator, text mining | PubMed |
| The emerging role of noncoding RNAs in systemic lupus erythematosus: new insights into the master regulators of disease pathogenesis. | Ther Adv Chronic Dis | 2023 | 37035097 | PubTator, text mining | PubMed |
| Global-feature of autoimmune glomerulonephritis using proteomic analysis of laser capture microdissected glomeruli. | Front Immunol | 2023 | 37033921 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1399/papers?page=10